Close Menu

NEW YORK (GenomeWeb) – Foundation Medicine today reported a sharp increase in preliminary revenue for the fourth quarter and full year 2015.

The company projects approximately $26.1 million in fourth quarter revenues, up 39 percent from $18.7 million in Q4 2014, and $93.2 million in full-year revenues, up 53 percent from $61.1 million in 2014. Analysts had estimated Q4 earnings of about $25 million for the company.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal reports that Russia's announcement of a coronavirus vaccine approval was met with concern as safety testing has not yet been completed.

New Scientist writes there aren't much data available on the accuracy of the two rapid COVID-19 tests the UK plans to roll out.

In PNAS this week: downstream effect of oncoprotein fusion, epigenetic changes influence tRNAs in colon cancer, and more.

Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.